William C. Baird Multiple Sclerosis Research Center, Jacobs Neurological Institute, University at Buffalo, The State University of New York, Buffalo, NY, USA.
J Neurosci Nurs. 2011 Feb;43(1):3-14; quiz 15-6. doi: 10.1097/jnn.0b013e31820297a9.
Despite notable advances in the understanding of multiple sclerosis (MS) and the availability of several treatment options, there is a need for therapies that are more effective, safe, convenient, and well tolerated. Several new oral MS therapies are being investigated. Because data on these new therapies continue to emerge, nurses will play a pivotal role in educating patients regarding the benefits and risks of potential treatments and in monitoring patients for response, safety, tolerability, and adherence. This article reviews the oral MS therapies recently approved as well as those currently in development or submitted for Food and Drug Administration approval.
尽管在多发性硬化症（MS）的认识方面取得了显著进展，并且有几种治疗选择，但仍需要更有效、安全、方便和耐受良好的治疗方法。正在研究几种新的口服 MS 治疗方法。由于这些新疗法的数据不断涌现，护士将在教育患者了解潜在治疗方法的益处和风险以及监测患者的反应、安全性、耐受性和依从性方面发挥关键作用。本文综述了最近批准的口服 MS 治疗方法，以及目前正在开发或提交给美国食品和药物管理局批准的治疗方法。
